India Vaccine Update: India has crossed more than 1 crore 19 lakh vaccination

▴ India Vaccine Update: India has crossed more than 1 crore 19 lakh vaccination
1 crore 19 lakh COVID-19 vaccine doses have been administered to the beneficiaries so far: Health Ministry

Union Health Ministry today said that more than 1 crore 19 lakh COVID-19 vaccine doses have been administered to the beneficiaries so far. These include 64,71,047 health care workers who have taken the 1st dose and 13,21,635 health care workers who have taken the 2nd dose. A total of 41,14,710 frontline workers have taken the 1st dose of the vaccine. A total of 1,61,840 vaccine doses were given till 6 p.m. yesterday, the 39th day of nationwide COVID-19 vaccination.

Briefing media in New Delhi, Health Secretary Rajesh Bhushan said, there are 12 States and Union Territories, in which the first dose has been administered to more than 75 per cent of the registered health care workers. He said, active cases are now less than 1.5 lakh which is 1.34 per cent of total cases and cumulative positivity rate is 5.19 per cent and it is declining. He said, two States - Maharashtra and Kerala account for 75 per cent of total active cases in the country.

The Health Secretary said that the Central Government will soon start administering the COVID-19 vaccine to the third category of the prioritized group comprising people who are above fifty years of age. He said the government will use the services of private hospitals in large numbers to expedite the pace of vaccination drive. He said, at present, an average of 10 thousand hospitals are being used for administering COVID-19 vaccines to the beneficiaries out of which two thousand hospitals are of the private sector.

Member (Health) in NITI Aayog Dr V. K. Paul said, 187 individuals detected with UK strain, six people with South African strain, and one with Brazilian strain to date. However, he said, there is no reason to believe, on the basis of scientific information, that it is responsible for the upsurge of outbreaks in some districts of Maharashtra and Kerala.

Director-General of Indian Council of Medical Research Dr Balram Bhargava yesterday clarified that there is no direct relation between the recent surge in COVID-19 cases in Maharashtra and some other states with the mutant virus strains N440K and E484Q of COVID-19. He also clarified that these two virus strains have been detected in other countries too and are not specific to India.

He further added, moreover, they have been found earlier in some states. He said the E484Q strain was earlier detected in four sequences in Maharashtra as early as March and July 2020. The N440K mutation has been reported on 13 different occasions between May and September 2020 in Telangana, Andhra Pradesh, and Assam.

He confirmed, the current upsurge in Maharashtra cannot be attributed to the currently discussed point mutations. Dr. Bhargava said that the situation is being constantly monitored.

Tags : #IndiaVaccinationUpdate #LatestVaccinationNews24thFeb #HealthMinistry #FrontlineWorkers #VaccinationDriveinIndia #IndiaFightsCorona #LatestNewsonUKStraininIndia

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Deworming in Children: A Crucial Step Towards Healthy GrowthFebruary 07, 2025
AI-powered blue-collar hiring platform Vahan.ai secures investment from APAC HR services leader Persol Group amid booming gig economy in India; plans to develop AI recruitment technology to support 8 major Indian languages February 07, 2025
Scars That Never Heal: The Painful Reality of Female Genital MutilationFebruary 06, 2025
Maharashtra’s Healthcare Betrayal: Why Are Crucial Funds Going Unused?February 06, 2025
1vision, 1 mission: Avaada Foundation’s CSR initiatives are powering communities and delivering sustainable progress across 5 key focus areasFebruary 06, 2025
Top 5 Technology Brands that are Transforming the Cancer Care Journeys for Hospitals and PatientsFebruary 06, 2025
Women's Wellness brand NUA Raises Rs 35 Crore in Pre-Series C led by Mirabilis Investment TrustFebruary 06, 2025
8 Effective Ways to Minimize Postpartum ComplicationsFebruary 06, 2025
Does Where You Live Decide Your Fate? The Urban-Rural Breast Cancer Divide in IndiaFebruary 06, 2025
Nepal leads the world with largest pictorial health warnings on all tobacco productsFebruary 05, 2025
Fleetguard Filters Private Limited Recognized for Excellence in CSR at Navabharat’s 4th CSR ConclaveFebruary 05, 2025
Six new regions of the Russian Federation are set to connect to Moscow's AI medical services platform, MosMedAIFebruary 04, 2025
Six new regions of the Russian Federation are set to connect to Moscow's AI medical services platform, MosMedAIFebruary 04, 2025
Ashok Leyland Reinforces ESG Commitment, Ranked No. 1 Globally in Sustainalytics’ RatingsFebruary 04, 2025
Calcium Supplements: Do You Really Need Them?February 04, 2025
Digital Diagnostics Doubles Its Foreign Publication Count in 2024February 04, 2025
World Cancer Day quotesFebruary 04, 2025
India can take a big leap in Cancer Care with Improved access to treatment and People-centered Approach: ExpertsFebruary 04, 2025
Lilly India appoints Winselow Tucker as the President and General ManagerFebruary 04, 2025
Driving Excellence in Clinical Research: ISCR's 18th Annual Conference Highlights Innovation, Technology, and Patient-CentricityFebruary 04, 2025